Preliminary analysis on the treatment of ventilator-associated pneumonia caused by pandrug-resistant Acinetobacter baumannii / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
; (6): 185-188, 2014.
Article
de Zh
| WPRIM
| ID: wpr-329850
Bibliothèque responsable:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To analyze the clinical features of pandrug-resistant Acinetobacter baumannii (PDR-Ab) in the Chinese PLA General Hospital and compare the efficacies of different antibiotic treatments in aged patients with ventilator-associative pneumonia (VAP) caused by PDR-Ab.</p><p><b>METHODS</b>Data were collected from all isolated PDR-Ab strains in our hospital from April 2009 to April 2010. The clinical features, treatment, and outcomes were retrospectively reviewed.</p><p><b>RESULTS</b>PDR-Ab was found to be the dominant pathogen in 42 of 126 aged VAP patients. Cefoperazone/sulbactam plus minocycline showed good efficacy in 20 patients with PDR-Ab VAP, showing a clinical cure rate of 65% (13/20) and a bacterial eradication rate of 40% (8/20). Another 22 patients were treated with other antimicrobial drugs, achieving a clinical cure rate of 22.7% (5/22) and a bacterial eradication rate of 13.6% (3/22). The factors influencing bacterial clearance were prolonged length of hospital stay and mechanical ventilation prior to positive culture (all P<0.01).</p><p><b>CONCLUSION</b>Cefoperazone/sulbactam plus minocycline can be an effective treatment for VAP caused by PDR-Ab.</p>
Texte intégral:
1
Base de données:
WPRIM
Sujet principal:
Sulbactam
/
Céfopérazone
/
Études rétrospectives
/
Résultat thérapeutique
/
Multirésistance bactérienne aux médicaments
/
Acinetobacter baumannii
/
Utilisations thérapeutiques
/
Traitement médicamenteux
/
Association de médicaments
/
Pneumopathie infectieuse sous ventilation assistée
Type d'étude:
Observational_studies
Limites:
Aged
/
Aged80
/
Female
/
Humans
/
Male
Langue:
Zh
Journal:
Acta Academiae Medicinae Sinicae
Année:
2014
Type de document:
Article